Literature DB >> 3894143

Effect of caerulein in patients with biliary colic pain.

N Basso, M Bagarani, A Materia, D Gizzonio, C De Paolis, C Praga, V Speranza.   

Abstract

A randomized placebo-controlled double-blind trial was carried out in 24 patients with biliary colic pain in order to evaluate the analgesic effect of caerulein (CRL). Caerulein (1 ng/kg . min infused intravenously over 15 min) showed an analgesic effect that was significantly higher than placebo (p less than 0.001). The analgesic action of CRL was not inhibited by naloxone (0.4 mg intravenously, administered two times). Further, the effect of i.v. CRL or saline on artificially induced biliary tree hypertension was studied in 7 patients with a T-tube common bile duct drainage. During saline intravenous administration, increasing biliary tree pressure resulted in pain in 5 patients, with the threshold for pain being 40 cmH2O. During CRL intravenous infusion, significantly higher perfusion pressures were required to achieve a given common bile duct pressure and the pressure threshold for pain was not reached. Consequently, pain was prevented in all patients. These data suggest that CRL relieves biliary colic pain by reducing biliary tract pressure.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3894143     DOI: 10.1016/0016-5085(85)90457-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  5 in total

1.  Increased sphincter of Oddi basal pressure in patients affected by gall stone disease: a role for biliary stasis and colicky pain?

Authors:  M Cicala; F I Habib; F Fiocca; N Pallotta; E Corazziari
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

2.  Sphincter of Oddi manometry. Paradoxical response to secretin but not to CCK in alcoholic patients with no pancreatic disease.

Authors:  R Laugier; R Gerolami; C Renou
Journal:  Int J Pancreatol       Date:  1998-04

3.  Paradoxical response of sphincter of Oddi to intravenous injection of cholecystokinin or ceruletide. Manometric findings and results of treatment in biliary dyskinesia.

Authors:  P Rolny; A Arlebäck; P Funch-Jensen; A Kruse; J Ravnsbaeck; G Järnerot
Journal:  Gut       Date:  1986-12       Impact factor: 23.059

4.  Effect of caerulein on abdominal pain following transcatheter hepatic arterial embolization in malignant liver cancer patients.

Authors:  K Ido; K Hiramatsu
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 5.  Rediscovery of Ceruletide, a CCK Agonist, as an Analgesic Drug.

Authors:  Jan M Keppel Hesselink
Journal:  J Pain Res       Date:  2020-01-15       Impact factor: 3.133

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.